Antioxidant properties of indole-3-pyruvic acid

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 291-298

  Politi, V ^a   D'Alessio, S ^a   Di Stazio, G ^a   De Luca, G ^a  

^a Polifarma Res Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; INDOL 3 YL PYRUVIC ACID; INDOL-3-YL PYRUVIC ACID; INDOLE DERIVATIVE; MUTAGENIC AGENT; SEROTONIN; TRYPTOPHAN;

ANIMAL; BIOLOGICAL MODEL; BRAIN; HUMAN; LIVER; MAMMAL; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SLEEP;

ANIMALS; ANTIOXIDANTS; BRAIN; HUMANS; INDOLES; LIVER; MAMMALS; MODELS, BIOLOGICAL; MUTAGENS; SEROTONIN; SLEEP; STRESS, PSYCHOLOGICAL; TRYPTOPHAN;

EID: 0030341952     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_46     Document Type: Article

References (38)

1. Atsumi, S., and Hayashi, T., 1979, Examination of the pronounced increase in auxin content of senescent leaves. Plant & Cell Physiol. 20: 861.
2. Bacciottini, L., Pellegrini-Giampietro, D.E., Bongianni, F., De Luca, G., Beni, M., Politi, V., and Moroni, F., 1987, Biochemical and behavioural studies on indole-pyruvic acid: a keto-analogue of tryptophan. Pharmacol.Res. Commun. 19: 803.
3. Baran, H., Okuno, E., Kido, R., and Schwarcz, R., 1994, Purification and characterization of kynurenine aminotransferase I from human brain. J.Neurochem. 62: 730.
4. Benuck, M., Stern, F., and Lajtha, A., 1971, Transamination of amino acids in homogenates of rat brain. J.Neurochem. 18: 1555.
5. Biagini, G., Merlo-Pich, E., Carani, C., Marrama, P., Gustafsson, J.A., Fuxe, K., and Agnati, L.F., 1993, Indolepyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression. Biol.Psychiat. 33: 712.
6. Brown, G.M., 1995, Melatonin in psychiatric and sleep disorders. CNS Drugs 3: 209.
7. Bruno, V., Canonico, P.L., Aronica, E., Nicoletti, F., and Scapagnini, U., 1991, Modulation of excitatory amino acid receptors by indolpyruvic acid. Neurosci.Res.Commun. 8: 137.
8. Chia, Y.C., Smith, G.W., and Lees, G.J., 1984, Differences in properties between aromatic amino acid: aromatic keto acid aminotransferases and aromatic aminoacid: alfa-ketoglutarate aminotransferases. Life Sci. 34: 2443.
9. Das, U.M., 1994, Melatonin: is it an endogenous anti-mutagenic, oncostatic and anti-ageing molecule? Med.Sci.Res. 22: 463.
10. El-Abyad, M.S., El-Sayed, M.A., El-Shanshoury, A.R., Farid, M., 1994, Optimization of culture conditions for indole-3-pyruvic acid production by Streptomices Griseoflavus. Can.J.Microbiol. 40: 754.
11. Fagni, L., Lafon-Cazal, L., Rondouin, G., Manzoni, O., Lerner-Natoli, M., and Bockaert, J., 1994, The role of free radicals in NMDA-dependent neurotoxicity. Progr.Brain Res. 103: 381.
12. Ferretti, C., Blengio, M., Ghi, P., and Genazzani, E., 1990, Differential effects of indolepyruvic acid and 5-hydroxytriptophan on indole metabolism in the pineal gland of the rat during the light-dark cycle. Europ.J. Pharmacol. 187: 345.
13. Green, C.B., Cahill, G.M., Besharse, J.C., 1995, Regulation of tryptophan hydroxylase expression by a retinal circadian oscillator in vitro. Brain Res. 677: 283.
14. Halliwell, B., 1992, Reactive oxygen species and the Central Nervous System. J.Neurochem. 59: 1609.
15. Hutzinger, O., Heacock, R.A., Macneil, J.D., Frei, R.W., 1972, Indoles and auxins. XIII. Identification and analysis of naturally occurring indoles via electron donor-acceptor complexes. J. Chromatogr. 68: 173.
16. Koga, J., Syono, K., Ichikawa, T., Adachi, T., 1994, Involvement of L-Tryptophan aminotransferase in indole-3-acetic acid biosynthesis in Enterobacter Cloacae. Biochim.Biophys.Acta 1209: 241.
17. Lavaggi, M.V., Politi, V., De Luca, G., Gorini, A., 1987, Effects of indole-3-pyruvic acid on tryptophan pyrrolase activity in "vitro" and "in vivo". In: Progress in Tryptophan and Serotonin Research 1986, W.de Gruyter & Co., Berlin, 51-54.
18. Lapin, I.P., 1980, Experimental studies on kynurenines as neuroactive tryptophan metabolites: past, present and future. TIPS 1: 410.
19. Lapin, I.P., and Politi, V., 1993, Anxiolytic effect of indole-3-pyruvic acid (IPA) in mice. Pharmacol.Res. 28: 129.
20. Lapin, I.P., and Politi, V., 1994, Antiethanol effects of indol-3-ylpyruvic acid (IPA) in mice. Alcohol and Alcoholism 29: 265.
21. Lissi, E.A., Faure, M., Montoya, N., Videla, L.A., 1991, Reactivity of indole derivatives towards oxygenated radicals. Free Rad.Res.Commun. 15: 211.
22. Merlo-Pich, E., Solfrini, V., Biagini, G., Fuxe, K., and Agnati, L.F., 1990, Effects of indole-pyruvic acid on sleep and food intake in the rat. Acta Physiol.Scand. 139: 583.
23. Moroni, F., Russi, P., Lombardi, G., Carlà, V., Alesiani, M., Cherici, G., and Moneti, G., 1990, Tryptophan metabolites and excitatory amino acid receptors: studies in physiology and pathology. In: Neurotoxicity of Excitatory Amino Acids, Raven Press, New York, 203-216.
24. Normanly, J., Slovin, J.P., Cohen, J.D., 1995, Rethinking auxin biosynthesis and metabolism. Plant Physiol. 107: 323.
25. Perkins, M.N., and Stone, T.W., 1985, Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo. Exptl.Neurol. 88: 570.
26. Poeggeler, B., Reiter, R.J., Tan, D-X, Chen, L-D, Manchester, L.C., 1993, Melatonin, hydroxyl radical-mediated oxidative damage, and ageing: a hypothesis. J.Pineal Res. 14: 151.
27. Politi, V., Lavaggi, M.V., Di Stazio, G., and Margonelli, A., 1991, Indole-3-pyruvic acid as a direct precursor of kynurenic acid. In: Kynurenine and Serotonin Pathways, Plenum Press, New York, 515-518.
28. Reiter, R.J., 1995, Oxidative processes and antioxidative defense mechanisms in the ageing brain. FASEB J. 9: 526.
29. Ruggeri, M., Merlo-Pich, E., Zini, I., Fuxe, K., and Agnati, L.F., 1990, Indole-pyruvic acid increases 5-hydroxy-indoleacetic acid levels in the cerebrospinal fluid and fronto-parietal cortex of the rat. A microdyalysis study. Acta Physiol.Scand. 138: 97.
30. Russi, P., Carlà, V., Moroni, F., 1989, Indolepyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory aminoacid receptors in vivo? Biochem.Pharmacol. 38: 2405.
31. Sapolsky, R.M. 1992, Stress, the Aging Brain, and the Mechanisms of Neuron Death. MIT Press, Cambridge.
32. Silvestri, R., Mento, G., Raffaele, M., De Luca, G., Buttini, G., Casella, C., Tisano, A., De Domenico, P., Di Rosa, A.E., Di Perri, R., 1991, Indole-3-pyruvic acid as a possible hypnotic agent in insomniac subjects. J.Intl. Med.Res. 19,:403.
33. Squadrito, F., Sturniolo, R., Trimarchi, G.R., Campo, G.M., De Luca, G., Gorini, A., and Caputi, A.P., 1990, Antihypertensive activity of indolpyruvic acid: a keto analogue of tryptophan. J.Cardiovasc. Pharmacol. 15: 102.
34. Squadrito, F., Calapai, G., Campo, G.M., Zingarelli, B., Arcoraci, V., Ioculano, M., Buemi, A.L., Cucinotta, D., Saitta, A., De Luca, G., Gorini, A., and Caputi, A.P., 1991, Indolepyruvic acid, a tryptophan keto analogue, reduces food intake in obese Zucker rats. Neurosci.Res.Cammun. 9: 27.
35. Taylor, M.W., and Feng, G., 1991, Relationship between interferon-gamma, indolamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5: 2516.
36. Walsh, H.A., Daya, S., Whiteley, C.G., 1994, Mode of inhibition of rat liver tryptophan 2,3-dioxygenase by melatonin. J.Pineal Res. 16: 188.
37. Zinner, K., Casadei de Baptista, R., and Cilento, G., 1974, Indole-3-pyruvic acid as a potential luciferin. Biochem.Biophys.Res.Commun. 61: 889.
38. Zoli, M., Merlo-Pich, E., Ferraguti, F., Biagini, G., Fuxe, K., and Agnati, L.F., 1993, Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat. Neurochem.Int. 23: 139.